FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window
Dear Sir(s)/ Madam(s), With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from June 30, 2020 till 48 hours of declaration of financial results for the quarter ended June 30, 2020. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Proceedings And Voting Result Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Dear Sir(s), With reference to the Postal Ballot Notice dated May 26, 2020, following resolutions have been approved with requisite majority through e-voting: - 1. Approval for entering into a Material Contract by Fortis Malar Hospitals Limited, a step-down subsidiary of the Company (Special Resolution). 2. Approval for waive off service fee payable to BT entities as described and amendment in any of the terms and conditions of Hospital and Medical Services Agreement (HMSA), including termination thereof (Special Resolution). 3. Approval of Appointment of Ms. Shailaja Chandra (DIN: 03320688) as an Independent Director of the Company (Special Resolution). 4. Approval for further Investment in Wholly Owned Subsidiary Companies of the Company. Please find enclosed Scrutinizer's Report along with result of postal ballot in prescribed format. Apollo to Fortis, hospitals not in the pink of health amid Covid-19 crisis
Analysts, too, are hopeful of the long-term prospects of hospital companies, but caution that the Covid-19 situation is evolving and near-term uncertainties continue Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts
Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in these counters? Here's what the charts suggest
Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts
Dr Avi Kumar, Consultant, Pulmonologist, Fortis Escort Heart Institute, said drugs such as Favipiravir and Remdisiver "cannot be called game changers" as they are used as a supportive treatment. Ex-Fortis promoter Malvinder's representation on bail criteria rejected
Singh moved the representation after his plea for interim bail was denied by the high court which gave him liberty to approach the committee if he was aggrieved by the criteria laid down by it
Buy Fortis Healthcare; target of Rs 153: ICICI Securities
ICICI Securities is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 153 in its research report dated June 18, 2020.
Fortis Healthcare says lockdown impacted operations, cuts fixed costs by 25%
The company said it does not expect any impact on its current ability to service debt FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, please find enclosed 'Investors Presentation on the Audited Financial Results'. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Outcome Of The Board Meeting
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. on June 17, 2020, inter-alia, considered and approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2020. M/s. B S R & Co. LLP, the Statutory Auditors of the Company have issued Audit Report with modified opinion along with Statement on Impact of Modified Opinion thereon. Please find enclosed 'Audited Financial Results, Audit Report, 'Statement of Assets & Liabilities' and Statement on Impact of Modified Opinion thereon for the year ended on March 31, 2020 along with a copy of press release being issued in this regard.